Loading...

Avanos Medical, Inc.

AVNS•NYSE
Healthcare
Medical - Devices
$24.66
$-0.05(-0.20%)
U.S. Market opens in 30h 28m

Avanos Medical, Inc. (AVNS) Stock Overview

Explore Avanos Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-16.86
EPS (TTM)$-1.57
ROE-0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$12.01
3 Months$17.86
1 Year Target$6.51

AVNS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Avanos Medical, Inc. (AVNS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 91.38, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $6.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.86 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.06%
5-Day Change
0.30%
1-Month Change
80.92%
3-Month Change
88.66%
6-Month Change
109.46%
Year-to-Date (YTD) Change
119.90%
1-Year Change
97.09%
3-Year Change
-20.29%
5-Year Change
-45.46%
All-Time (Max) Change
-39.77%

Contact Information

https://avanos.com
844 428 2667
5405 Windward Parkway, Alpharetta, GA, 30004

Company Facts

2,227 Employees
IPO DateOct 21, 2014
CountryUS
Actively Trading

Frequently Asked Questions